Artemisinin resistant <i>kelch13</i> R622I and RDT negativity approaching predominance in northern Ethiopia and emerging C580Y of African origin threaten falciparum malaria control
Ayalew Jejaw Zeleke(University of Gondar), Jeffrey A. Bailey(John Brown University), Rebecca Crudale(Brown University), Bokretsion G. Brhane(Ethiopian Public Health Institute), Jonathan B. Parr(University of North Carolina at Chapel Hill), Ashenafi Assefa(University of North Carolina at Chapel Hill), Patience Kiyuka(Kenya Medical Research Institute), George A. Tollefson(Brown University), Mulugeta Aemero(University of Gondar), Abebe A. Fola(John Brown University), Alec Leonetti(Brown University), Asrat Hailu(Addis Ababa University), Karamoko Niaré(The Stables), Jacob Marglous(Brown University), Om Taropawala(Brown University)
Cited by 3
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147